Bridgeway Capital Management’s Fulcrum Therapeutics FULC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $671K | Hold |
97,600
| – | – | 0.02% | 719 |
|
|
2025
Q1 | $281K | Sell |
97,600
-42,400
| -30% | -$122K | 0.01% | 850 |
|
|
2024
Q4 | $658K | Buy |
+140,000
| New | +$658K | 0.01% | 763 |
|
|
2024
Q2 | – | Sell |
-88,564
| Closed | -$836K | – | 1297 |
|
|
2024
Q1 | $836K | Sell |
88,564
-37,936
| -30% | -$358K | 0.02% | 789 |
|
|
2023
Q4 | $854K | Hold |
126,500
| – | – | 0.02% | 792 |
|
|
2023
Q3 | $562K | Hold |
126,500
| – | – | 0.01% | 845 |
|
|
2023
Q2 | $417K | Buy |
+126,500
| New | +$417K | 0.01% | 958 |
|
|
2023
Q1 | – | Sell |
-40,000
| Closed | -$291K | – | 1400 |
|
|
2022
Q4 | $291K | Sell |
40,000
-35,000
| -47% | -$255K | 0.01% | 996 |
|
|
2022
Q3 | $607K | Buy |
+75,000
| New | +$607K | 0.02% | 848 |
|